PM · Philip Morris International Inc
Price
Snapshot
50 fields · last close| Market Cap | $290.2B |
| P/E | 26.84 |
| Float | 1.56B |
| Beta | 0.39 |
| Volatility | 9.8% |
| Exchange | NYSE |
| Sector | Tobacco |
| Cap tier | Mega cap |
| Macro sensitivity | Low |
| Clavix score | 76 |
| Price | 182.69 |
| Change | −1.87% |
| Prev Close | 186.17 |
| Open | 188.65 |
| Day Low | 186.06 |
| Day High | 189.09 |
| Avg Vol | 4 |
| Avg $ Vol | $750.8M |
| 52W High | 207.76 |
| 52W Low | 142.11 |
| 52W Pos | 61.8% |
| From High | −12.07% |
| From Low | +28.56% |
| Max DD 1Y | −19.26% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | −3.33% |
| SMA 50 | −2.75% |
| SMA 200 | +4.84% |
| RSI (14) | 45.5 |
| Vol 30D | 23.7% |
| Vol 90D | 29.3% |
| 1Y Range | 142–208 |
| Daily bars | 506 |
| Perf Week | −2.26% |
| Perf Month | −1.46% |
| Perf Quarter | +6.39% |
| Perf Half Y | +9.71% |
| Perf Year | +14.06% |
| Perf YTD | +13.97% |
| Prev Day | −1.87% |
| Clavix | B |
| Debt / Eq | 80.98 |
| Curr Ratio | 0.96 |
| Int Cover | 17.3× |
| FCF Margin | 32.3% |
| Rev Growth | +10.4% |
| Profit | Profitable |
| Leverage | Very High |
| Sector rank | 1 / 2 |
What PM does
Philip Morris International Inc. operates as a tobacco company.
The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches.
It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Clavix risk grade
regraded every trading dayPM grades B, 76 of 100. Steadiest on Macro Resilience (66), most exposed on Sector Resilience (55, mixed). 2 of the 4 weighted dimensions sit above the all-names median. Ranks 1 of 2 in Tobacco by Clavix score.
How rough the ride is
| PM | |
|---|---|
| Betavs the overall market · lower is steadier | 0.39 |
| Volatilityannualized | 9.8% |
| Max drawdown, past yearworst peak-to-trough fall | −19.3% |
| Typical daily movemedian absolute daily change | 1.07% |
| Days beyond ±3%of the last 252 sessions | 239% |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| PM | all-names median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.39 | — |
| Macro sensitivityrate, dollar and credit exposure bucket | Low | Low100% of 2 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many all-names names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| PM | |
|---|---|
| 1 week | −2.3% |
| 1 month | −1.5% |
| Year to date | +14.0% |
| 1 year | +14.1% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| PM | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 23 Jul |
| Average score0 most bearish, 100 most bullish | 67 |
| Bullish · bearisharticles above 60 · below 40 | 23 · 4 |
| Directionarticles whose tone is improving vs worsening | 23 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the Tobacco names Clavix covers; the tick is the sector median.
Growth
| PM | |
|---|---|
| Revenue growthyear over year | +10.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the all-names median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openPhilip Morris International has shifted its business away from declining cigarettes and toward smoke-free products that grow faster and earn better profit margins. Strong second-quarter results indicate this transition is now producing solid financial performance.
Ferguson Wellman Capital Management cut its Philip Morris International holdings by 1.3% in the second quarter, leaving it with 476,411 shares. The article body is truncated and provides no further detail or stated reason for the sale.
The FDA has cleared Juul to sell an updated e-cigarette called Juul2, which includes an age-verification system, along with new tobacco- and menthol-flavored cartridges.
An analyst argues Philip Morris's premium share price is justified by its pricing power across IQOS, ZYN, VEEV One, and Marlboro, noting that smoke-free products now make up over 41% of revenues. The analyst also expects PM to announce another dividend increase in September.
Philip Morris received FDA authorization to sell 11 new ZYN ULTRA nicotine pouches in the United States, adding to its smoke-free product lineup. The article frames this as support for the company's longer-term move away from cigarettes.
Nearest peers by size
Tobacco
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.